Prolongation of survival of heterotopic heart xenografts by antibody and complement suppression in primates.
Mieny
C J
CJ
Department of Surgery, University of Pretoria, South Africa, England.
Karusseit
V O
VO
Van den Bogaerde
J B
JB
Hasan
R I
RI
White
D J
DJ
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002522:Chlorocebus aethiops; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D008727:Methotrexate / Q000627:therapeutic use; D010215:Papio; D014183:Transplantation, Heterologous / Q000276:immunology*; D016042:Transplantation, Heterotopic
D016572:Cyclosporine; D008727:Methotrexate